US 12030940
Immunotherapeutic tumor treatment method
granted A61KA61K2039/505A61K31/77
Quick answer
US patent 12030940 (Immunotherapeutic tumor treatment method) held by Nektar Therapeutics expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K31/77, A61K45/06, A61P